Eyenuk

Eyenuk is an AI retinal-screening platform for primary care and organized screening programs, detecting diabetic retinopathy, diabetic macular edema, and related retinal conditions.

1. Clinical role: It supports autonomous retinal screening and care routing rather than replacing ophthalmologists, so specialist follow-up remains essential after positive results.
2. Best-fit environment: Diabetic and multi-disease screening programs fit best where primary care sites have established referral pathways and compatible imaging hardware.
3. Evaluation priorities: Buyers should confirm regulatory clearance, camera compatibility, validation depth, referral integration, reporting, and support before broader rollout.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than published, making implementation requirements important purchasing considerations.

Eyenuk is best evaluated as a screening layer whose value depends on workflow placement, specialist follow-up, and coordinated deployment across participating sites.